InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: dmlcento post# 225834

Thursday, 11/14/2019 12:34:26 PM

Thursday, November 14, 2019 12:34:26 PM

Post# of 424405
Overall my thoughts, AMRN very well prepared, FDA fumbling, FDA believes M.O. is not an issue and is off the table. 2 Adcom members , one conflicted and one have statistical issues seem to have problems with data. Hopefully AMRN will get a change to follow back up with answers the FDA could not answer in that last "clarifying questions" section.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News